Breaking News, Collaborations & Alliances

Charles River, Aitia Partner on Neurodegenerative Diseases, Oncology

Partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology research.

Charles River Laboratories International, Inc. and Aitia, a company involved in the application of Causal AI and Digital Twins, entered into a strategic agreement that gives Aitia access to Logica, Charles River’s Artificial Intelligence (AI) powered drug solution platform, for the optimized discovery and early development of multiple therapeutic programs for neurodegenerative disease and oncology. Aitia will deploy Logica across their portfolio of novel drug targets with the aim of adv...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters